Sun Pharma-Organon $11.75-Billion Deal Signals India Inc’s Rising Global M&A Ambitions
India’s corporate landscape has witnessed a landmark moment with Sun Pharma’s $11.75-billion acquisition of Organon, a global pharmaceutical company. The deal not only strengthens Sun Pharma’s international footprint but also signals the rising ambitions of India Inc in global mergers and acquisitions (M&A). Key Highlights of the Deal Transaction Snapshot Category Details Deal Value $11.75…